U.S. market Closed. Opens in 11 hours 16 minutes

KRTX | Karuna Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue654.00K10.64M36.96MN/AN/AN/AN/A
Cost of Revenue1.70M1.11M506.00K145.00K58.00KN/AN/A
Gross Profit-1.05M9.53M36.46M-145.00K-58.00KN/AN/A
Operating Expenses495.43M300.31M180.82M71.82M45.41M14.51M4.81M
Selling, General & Admin131.33M76.07M52.62M28.41M20.87M2.97M1.19M
Research & Development364.10M224.25M128.20M43.41M24.54M11.54M3.62M
Other Operating Expenses588.00K580.00K254.00KN/AN/AN/AN/A
Operating Income-494.78M-289.68M-143.85M-71.82M-45.41M-14.51M-4.81M
Other Expenses / Income588.00K14.76M54.00K3.31M1.45M-444.00K-1.23M
Before Tax Income-433.01M-274.92M-143.80M-68.51M-43.96M-17.51M-6.03M
Income Tax Expenses670.00K1.42M6.00K43.00K887.00K-419.00KN/A
Net Income-433.68M-276.34M-143.81M-68.55M-44.84M-17.51M-6.03M
Interest ExpensesN/A14.18MN/AN/A945.00K2.58M1.17M
Basic Shares Outstanding36.96M31.63M29.14M26.45M11.96M10.87M7.42M
Diluted Shares Outstanding36.96M31.63M29.14M26.45M11.96M10.87M7.42M
EBITDA-493.08M-289.68M-143.15M-68.51M-42.88M-14.48M-4.86M
EBITDA Margin-75,393.88%-2,723.29%-387.27%0.00%0.00%0.00%0.00%
EBIT-433.01M-260.74M-143.80M-68.51M-43.01M-15.35M-4.86M
EBIT Margin-66,209.48%-2,451.26%-389.02%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙